Nexvet Biopharma plc Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Nexvet Biopharma (NVET) IPO Opens Down 9%
February 5, 2015 11:06 AM ESTToday's IPO for Nexvet Biopharma (Nasdaq: NVET) opened for trading at $9.12 after pricing 4,000,000 ordinary shares at a price to the public of $10.00 per share, below the expected $13.00-$16.00 range.
BofA Merrill Lynch and Cowen and Company are acting as joint lead book-running... More
